Fundamental Analysis
70 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +147.0% | +48.3% | 2 / 3 | +170.5% | -1.63 pp | -0.40 pp | +7.9% | 0.62 | 10.77 | 775 | +170,5% | 32,5 | +147,0% | 10.77 | 18.68 | −42,3% |
| Pts | 12 | 12 | 8 | 12 | 4 | 4 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 17.150 (close price on 2026-10-16)EPS (TTM): 1.592
Financial charts
1.Revenue & growth
VND bn775Q2/26
1.Revenue & growth
VND bn775Q2/26
2.Profit & growth
VND bn32,4Q2/26
3.Profit mix (Penman)
VND bn65,5Q2/26
4.Margins & cost structure
%4.9%Q2/26
5.Returns & cash cycle
% · days4.5%Q2/26
6.Earnings quality & cash
VND bn-61,4Q2/26
7.Asset structure
VND bn2.024Q2/26
8.Funding & debt health
VND bn · times2.024Q2/26
9.Revenue backlog
VND bn74,1Q2/26
10.Valuation
times · %10,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.007Q2/26
Adjusted EPS growth, latest quarter
146%
Average adjusted EPS growth, 3 quarters
48.1%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26